Sperm capacitation is a maturation step that is deemed to be essential for sperm to fertilize an oocyte. A family of proteins, the binder of sperm (BSP), are known to bind choline phospholipids on sperm membranes and promote capacitation in bulls and boars. Recently, BSP-homologous genes have been identified in the epididymal tissues of human (BSPH1) and mouse (Bsph1, Bsph2). The aim of this study was to determine the binding characteristics of the murine binder of sperm protein homolog 1 (BSPH1) and evaluate its effects on sperm capacitation. Since it is not possible to purify the native BSP proteins from human and mouse in sufficient quantity, a murine recombinant BSPH1 (rec-BSPH1) was produced and used for the functional studies. Similarly to BSP proteins from other species, rec-BSPH1 bound to gelatin, heparin, phosphatidylcholine liposomes, and sperm. Both native BSPH1 and rec-BSPH1 were detected on the head and the midpiece region of sperm, although a stronger signal was detected on the midpiece region when sperm were incubated in a capacitating media containing bovine serum albumin. More importantly, murine rec-BSPH1 was able to capacitate sperm, but was unable to induce the acrosome reaction. These results show that murine epididymal BSPH1 shares many biochemical and functional characteristics with BSP proteins secreted by seminal vesicles of ungulates, and suggest that it might play a similar role in sperm functions.
INTRODUCTION
Testicular sperm released into the seminiferous tubule lumen do not have the ability to fertilize an oocyte. They acquire this ability gradually during their transit through the epididymis, via interactions with components of accessory gland secretions following ejaculation and during their journey in the female genital tract. One of the key steps of sperm maturation is the capacitation. It is broadly defined as a series of biochemical and physiological modifications, which take place in the female genital tract and render the sperm competent to fertilize an egg [1, 2] . These modifications include changes in the lipid composition of the sperm plasma membrane, increase in intracellular pH, increased permeability to ions, such as calcium, and increased tyrosine phosphorylation of a group of signaling proteins [3] [4] [5] [6] [7] .
Capacitation can be induced in vitro by incubating sperm in defined capacitation media. The most commonly used media contain all the essential components for sperm capacitation, including bovine serum albumin (BSA), calcium, and bicarbonate. BSA has been shown to be a critical component of in vitro capacitation, as it removes cholesterol from the sperm plasma membrane and induces protein phosphorylation and calcium influx [8, 9] .
The binder of sperm (BSP) proteins (called bovine seminal plasma proteins prior to the new nomenclature [10] ) have been thoroughly studied in the last 25 years. They were first identified in the bovine seminal plasma, where the three BSP proteins (BSP1, BSP3, and BSP5, previously called PDC-109 or BSP-A1/A2, BSP-A3, and BSP-30K, respectively) represent approximately 60% of the total seminal plasma proteins [11] [12] [13] . These proteins, secreted by the seminal vesicles, can bind to sperm via an interaction with choline phospholipids and promote capacitation induced by glycosaminoglycans (GAGs) and high-density lipoproteins (HDL) [14] [15] [16] [17] . Recently, bovine BSP proteins were attributed with other functions, including the mediation of sperm binding to the oviductal epithelium, and the ability to prolong sperm survival and motility in the oviduct [18] . Studies also reported a chaperone-like activity for BSP1 [19] .
BSP proteins were identified in the seminal plasma of other species, such as boar, ram, goat, stallion, and bison [20] [21] [22] [23] [24] [25] . These proteins are structurally similar to bovine BSPs, as they are all composed of a variable N-terminal domain followed by two fibronectin type II (Fn2) domains arranged in tandem [10] . They also share many biochemical and functional characteristics, such as their capacity to bind to gelatin, GAGs, HDL, and low-density lipoproteins, and their ability to promote sperm capacitation [17, 22-24, 26, 27] .
The BSP Fn2 domains have special features that set them apart from other Fn2 domain-containing proteins, such as fibronectin, blood coagulation factor XII, and 72 kDa and 92 kDa type IV collagenases [28] . These features were used to identify new BSP-related sequences in the genome of different species [28] . Two BSP-homologous genes in mouse (Bsph1 and Bsph2; accession numbers DQ227498 and DQ227499) and one in human (BSPH1; accession number DQ227497) were identified [28] . As opposed to the other members of the BSP family, human and mouse proteins were found to be expressed exclusively in the epididymis [29] . Furthermore, human BSPH1 represents only a small quantity of the total seminal plasma proteins [29] .
BSP proteins play an important role in the capacitation of bovine and porcine sperm [15-18, 26, 30, 31] . It is possible that the human and mouse homologs would also be implicated in sperm capacitation. The aim of this study was to determine the binding characteristics of the murine BSP protein homolog 1 (BSPH1) and evaluate its effects on sperm capacitation. Since it is not possible to purify native BSP proteins from mouse in sufficient quantity, a recombinant murine BSPH1 (rec-BSPH1) was expressed, purified, and used for the functional studies. Murine BSPH1 is orthologous to the human BSPH1. Therefore, the study of BSP proteins using a mouse model could give new insight on the functions and importance of the human BSPH1 protein in male fertility.
MATERIALS AND METHODS

Animals
Pathogen-free ICR outbred mice derived from animals from Charles River Laboratories (Wilmington, MA) were purchased from Harlan Laboratories (Indianapolis, IN) and were kept in the animal care facility of the research center. Studies were approved by the Maisonneuve-Rosemont Hospital ethics committee, and mice were treated according to the guidelines of the Canadian Council of Animal Care.
Cloning of cDNA Sequence into the Expression Vector
For the expression of the N-terminal His-tagged BSPH1, murine epididymal cDNA was used as template for PCR amplification of Bsph1. To clone the Bsph1 coding sequence in a pET15b vector (Novagen, EMD Biosciences, La Jolla, CA), the following oligonucleotide primers were used: Bsph1-F1 (BamHI) 5 0 -CGC GCT AGC CAA GTA GAA GAT TAT TAT GCA CC-3 0 and Bsph1-R1 (NheI) 5 0 -GCG GCT AGC CAA GTA GAA GAT TAT TAT GCA CC-3 0 . For the expression of BSPH1 fused to a thioredoxin-(His) 6 -S-tag, the pET15b-Bsph1 vector was used as template. The following oligonucleotide primers were used to allow the subcloning in the pET32a expression vector (Novagen): Bsph1-F2 (NcoI) 5 0 -GTC GCC ATG GCC TTT CAA GTA GAA GAT TAT TAT GCA CC-3 0 and Bsph1-R2 (BamHI) 5 0 -CGC GGA TCC TCA  CTC TAT ACA ATA TTT CCA AAC-3 0 . The PCR was done using a pfu polymerase (Fermentas, Burlington, ON, Canada) under the following cycles: initial denaturation at 948C for 3 min, 33 cycles of 948C, 45 sec; 608C, 45 sec; 728C, 1 min, and a final elongation step of 728C for 7 min. Taq polymerase (GE Healthcare, Baie d'Urfé, PQ, Canada), was added before the final elongation step to allow subcloning in a pCR2.1 vector (Invitrogen, Carlsbad, CA). The Bsph1 coding sequence was then extracted from the pCR2.1 vector, and the pET32a expression vector was linearized using the proper restriction enzymes (England BioLabs, Beverly, MA). Digested products were run on agarose gel, purified using Qiaex II gel extraction kit (Qiagen, Mississauga, ON, Canada), and ligated overnight using T 4 DNA ligase (Invitrogen). Ligation reactions were transformed into competent DH5a cells, and plasmid DNA was isolated using the QIAprep spin miniprep kit (Qiagen). Sequences were confirmed using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA) and the ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
Protein Expression in Escherichia coli
The positive plasmids were transformed in Origami B (DE3)pLysS competent cells (Novagen) using standard methods. Transformed cells were then plated on Luria-Bertani (LB)-agar plates containing 100 lg/ml of ampicillin (Sigma-Aldrich, Oakville, ON, Canada) and incubated at 378C overnight, after which single colonies were inoculated in liquid LB medium containing the same concentration of ampicillin. For the protein expression, 250 ml of LB medium containing the same antibiotic was inoculated with 1/100 volume of overnight culture, and bacteria were incubated at 378C with shaking at 200 rpm until optical density at 600 nm reached 0.6-0.8. To induce the expression, IPTG (Invitrogen) was added to the cell culture to a final concentration of 1 mM, and the cells were incubated at 158C and 200 rpm for 16 h. Following the induction, cells were harvested by centrifugation at 6000 3 g for 10 min at 48C.
Immobilized Metal Ion Affinity Chromatography and Refolding
Cell pellets were resuspended in B-Per bacterial protein extraction reagent (Pierce, Rockford, IL), as described by the manufacturer, and subjected to sonication (five cycles of 10 sec on ice). One volume of 43 binding buffer (2 M NaCl, 80 mM Tris-HCl, 20 mM imidazole, pH 7.4) was added to the cell lysate. Urea was added for a final concentration of 6 M, and the volume was adjusted with water to four times the initial volume. The cell extract was finally centrifuged at 25 000 3 g for 30 min to separate the soluble and insoluble fractions. The soluble fraction was filtered through a 1-lm filter and loaded on a column (1 cm 3 15 cm) containing 5 ml of His-Bind resin (Novagen) charged with Ni 2þ and equilibrated with 13 binding buffer containing 6 M urea at a flow rate of 24 ml/h. The column was then washed with 5 bed volumes of 13 binding buffer and 5 bed volumes of washing buffer (500 mM NaCl, 20 mM Tris-HCl, 80 mM imidazole, 6 M urea, pH 7.4). The refolding of the bound proteins was done on-column with a decreasing urea gradient (6-0 M) in 13 binding buffer (modified from [32] ). Finally, the refolded proteins were eluted with three successive elution buffers containing different imidazole concentrations (500 mM NaCl, 20 mM Tris-HCl, pH 7.4, containing 100, 200, and 400 mM imidazole, respectively). Based on optical density of fractions, similar quantities of all samples were precipitated with TCA (final concentration, 15%) and analyzed by SDS-PAGE and Western blotting. Proteins were also extracted from polyacrylamide gel and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) [33] . Trx-His-S control was prepared in the same way using Origami B (DE3)pLysS containing empty pET32a vectors, and were purified by immobilized metal ion affinity chromatography in the absence of urea.
Protein Electrophoresis and Western Blotting
SDS-PAGE was performed according to the method of Laemmli [34] in 12% or 15% gels using the Mini-Protean 3 apparatus from Bio-Rad (Mississauga, ON, Canada). Gels were either stained with Coomassie Brilliant Blue R-250 (Bio-Rad), or transferred electrophoretically to Immobilon-P PVDF membranes (Millipore, Nepean, ON, Canada). Immunodetection was performed using His-Probe mouse monoclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), affinity-purified antibodies against a synthetic peptide corresponding to the last 15 C-terminal amino acids of the deduced sequence of BSPH1, affinity-purified antibodies against (His) 6 -tagged recombinant BSPH1 (described below), or affinity-purified antibodies against bovine BSP1 at a concentration of 1:1000 [17] . Goat anti-mouse IgG (1:3000) or goat anti-rabbit IgG (1:10 000) were used as secondary antibodies (Bio-Rad). The bands were revealed using a chemiluminescence reagent (Perkin-Elmer, Boston, MA) and a Fuji LAS-3000 image analyzer (Fujifilm; Stamford, CT).
Generation of Antibodies Against BSPH1
The polyclonal antibodies against murine BSPH1 were produced as described previously by Lefebvre et al. [35] . Briefly, a 15-amino acid peptide corresponding to the C terminus of murine BSPH1 (SLTPNYNKDQVWKYC) was synthesized and conjugated to keyhole limpet hemocyanin at the Sheldon Biotechnology Center (Montreal, PQ, Canada). New Zealand rabbits were injected hypodermically with a homogeneous mixture of 200 lg conjugated peptide dissolved in 100 ll of 50 mM PBS, 400 ll of sterile 0.9% NaCl, and 500 ll of Freund complete adjuvant (Sigma-Aldrich). Boosts were performed at 20-day intervals over a period of 88 days, with 200 lg of the same antigen in the mixture, except that Freund incomplete adjuvant was used instead of complete adjuvant (Sigma-Aldrich). Bleedings were performed 15 days after each injection. Antiserum from the third boost was used for the present study (anti-BSPH1).
For the production of antibodies against the (His) 6 -tagged full-length recombinant BSPH1 (anti-rec-BSPH1), the protein was expressed as described previously [35] , and the inclusion bodies were isolated according to the instructions in the Novagen protocol handbook. For each injection, ;175 lg protein equivalents were run on a 10% SDS-PAGE gel. A total of 15 lg of protein was run in another lane, which was cut from the gel and stained with Coomassie Brilliant Blue. After staining, the gels were aligned and the portion of the unstained gel corresponding to BSPH1 protein was excised. Gel slices were minced in 1-ml saline solution and homogenized using a polytron. An equal volume of Freund complete (first injection) or incomplete (subsequent injections) adjuvant was added, and the solution was emulsified. New Zealand rabbits were immunized as described above. Antiserum from the third boost was used for the present study. Rabbits were treated in accordance with the guidelines of the Canadian Council of Animal Care.
Both antisera were passed through a Protein-A-Sepharose column to isolate the antibodies. Using the same concentration (1:1000), both antibodies gave similar results in Western blots. Preimmune rabbit serum was also passed through a Protein-A-Sepharose column to purify IgG antibodies used as control (IgG).
For the inhibition of capacitation assays, anti-rec-BSPH1 antibodies were further purified on a rec-BSPH1-Affi-gel 15 column. Rec-BSPH1 proteins were coupled to Affi-Gel 15 resin (Bio-Rad) as described by the manufacturer. The antibodies isolated in the previous step were passed through the column and bound antibodies were eluted using PBS containing 0.1 M glycine (pH 2.5).
PLANTE ET AL.
Affinity Chromatography
All operations were carried out at 48C. Heparin-Sepharose CL-6B resin was purchased from Amersham Biosciences (Baie d'Urfé, PQ, Canada). The coupling of gelatin to agarose beads was performed as previously described [13] . Chondroitin sulfate B (Sigma-Aldrich) was coupled to Affi-gel 15 as previously described [17] , with the exception that 4 mg of commercial chondroitin sulfate B was coupled to 20 ml of resin. For each experiment, 5 ml of resin was packed in a column (1 cm 3 15 cm) and equilibrated with 50 mM Tris-HCl buffer (TB; pH 7.4). Since rec-BSPH1 is barely soluble in high concentrations, diluted solutions were used. A total of 500 lg of rec-BSPH1, or control Trx-His-S dissolved in 5 ml of TB, were applied to the column at a flow rate of 2 ml/h, and the flow was stopped for 30 min. The unbound material was then washed from the column with TB, and the column was successively washed with TB containing 1 M NaCl and TB containing 8 M urea. For the gelatin-agarose affinity chromatography, the column was washed with TB and eluted directly with TB containing 8 M urea. The protein fractions from each peak were pooled, and approximately 3 lg of protein from each peak was precipitated with TCA and analyzed by SDS-PAGE. For quality control, alcohol precipitates of bovine seminal plasma proteins were run similarly on each column.
Binding to Phosphatidylcholine Liposomes
Phosphatidylcholine (PC) liposomes were prepared as previously described [14] . Briefly, 10 mg of PC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; Avanti Polar Lipids Inc., Alabaster, AL) were evaporated under N 2 to form a thin film at the bottom of a glass test tube. Buffer A (2 ml; 10 mM Tris-HCl, 100 mM KCl, pH 7.5) was added to the tube and sonicated in a Branson ultrasonic water bath (model 3510) for approximately 20 min at room temperature. Small unilamellar liposomes were sedimented at 100 000 3 g for 30 min at 258C and resuspended in 1 ml of buffer B (10 mM Tris-HCl, 100 mM KCl, 2.5 mM CaCl 2 , pH 7.5). To study the binding of rec-BSPH1 (20 lg), thioredoxin (20 lg), or bovine BSP1 (10 lg) to PC liposomes, the indicated amount of proteins was incubated with 300 lg of liposomes in 300 ll of buffer B for 40 min at room temperature. Liposomes were then sedimented at 100 000 3 g for 45 min. An equal volume of supernatant and pellet was treated with TCA (final concentration, 15%), and precipitated proteins were analyzed by Western blot.
Preparation of Sperm
Cauda epididymides and vas deferens were removed immediately after male mice (.12 wk old) were killed by cervical dislocation. Epididymides were minced in 1 ml of prewarmed modified Krebs-Ringer medium (Whitten HEPES [WH] buffered medium) and placed at 378C for 10 min to allow motile sperm to swim out [36] . Motile sperm were then collected, washed once with 5 ml of WH media (10 min at 200 3 g), and resuspended in 500 ll of WH media.
Binding to Sperm
To study the binding of rec-BSPH1 to mouse sperm, 10 3 10 6 sperm were incubated 1 h at 378C in the presence or absence of 10 lg of rec-BSPH1 in 1 ml of WH media containing Complete Mini, EDTA-free protease inhibitor tablet (1 tablet/10 ml; Roche, Manheim, Germany) and 1 mM of PMSF. Following the incubation, the sperm were pelleted at 5000 3 g for 10 min. The supernatant was removed and the pellet was washed three times with 1 ml of WH medium. The supernatant and wash fractions were precipitated with TCA (final concentration, 15%), resuspended in Laemmli sample buffer, and boiled for 10 min. The pellet was resuspended in sample buffer, boiled 10 min, and sonicated for 1 h in a Branson ultrasonic water bath (model 3510). The different fractions were analyzed by SDS-PAGE and Western blot.
Capacitation/Inhibition of Capacitation Assay
Sperm were collected as described above. For capacitation studies, 2 3 10 6 washed sperm were incubated for 1 h at 378C in 1 ml WH media supplemented or not with BSA (5 mg/ml), in the presence of different concentrations of rec-BSPH1, Trx-His-S, or without protein as control.
For inhibition experiments, washed sperm (2 3 10 6 ) were incubated in WH media supplemented or not with 5 mg/ml BSA in the presence of different concentrations of the anti-rec-BSPH1 antibodies or IgG isolated from normal rabbit serum as control.
Following the incubation with the antibodies or recombinant proteins, 200 ll of the sperm suspension were incubated for an additional 30 min at 378C with or without 5 lM calcium ionophore A23187 (Sigma-Aldrich). Sperm were then fixed with 200 ll of 8% paraformaldehyde for 30 min at room temperature, centrifuged for 2 min at 8000 3 g, and washed twice with 0.1 M ammonium acetate (pH 9.0). They were resuspended in a final volume of 100 ll of the same solution, and 20 ll were smeared on microscopic slides.
Slides were then dried and stained using the Coomassie Brilliant Blue staining technique [37] . Briefly, the slides were put successively in water, methanol, and water for 5 min each and stained for 2 min in a solution of 0.22% Coomassie Blue G-250 in 50% methanol and 10% acetic acid solution. A total of 400 sperm was counted for each condition.
Chlortetracycline (CTC) staining was slightly modified from that described by Ward and Story [38] . After incubation with the different concentrations of rec-BSPH1, anti-BSPH1, or controls, 50 ll of sperm suspension were mixed with 50 ll of CTC solution (5 mM cysteine, 750 lM CTC, 20 mM Tris base, and 130 mM NaCl, pH 7.8). After 30 sec, the reaction was stopped using 12.5 ll of glutaraldehyde (12.5%). Two 15-ll droplets of this mixture were placed on a slide and covered with a cover slip. The slides were kept overnight in the dark at 48C in a humid environment. The slides were then observed with a Leitz Diaplan fluorescent microscope under blue-violet illumination (excitation at 330-380 nm, emission at 420 nm).
Immunolocalization of rec-BSPH1 on Sperm
To determine which regions of the sperm binds rec-BSPH1, sperm were prepared as described for the capacitation assays. Sperm were incubated for 1 h in WH media without any added proteins, with 15 lg rec-BSPH1, or 7 lg TrxHis-S as control in the presence or absence of BSA (5 mg/ml). Following the 30-min incubation with or without calcium ionophore, 200 ll of sperm suspension were fixed with 200 ll of 4% paraformaldehyde for 30 min at room temperature. The sperm were then washed three times with PBS and allowed to dry on Poly-L-lysine microscopic slides (Fisher Scientific, Ottawa, ON, Canada). Sperm were permeabilized with PBS containing 0.1% Triton-X-100 and 0.2% paraformaldehyde, washed three times with PBS, and incubated for 1 h at room temperature in PBS containing 1% BSA. Slides were then incubated for 1 h at room temperature with anti-rec-BSPH1 antibodies, mouse His-probe antibodies, or IgG as control at a dilution of 1:100 in PBS 0.1% BSA, washed three times with PBS to remove excess antibodies, and incubated for 1 h at room temperature with fluorescein isothiocyanate (FITC)-conjugated goat antirabbit IgG or FITC-conjugated goat anti-mouse IgG (Sigma-Aldrich) at a dilution 1:200 in PBS 0.1% BSA. All slides were then washed three times with PBS and counterstained with 5 lg/ml Hoechst 33342 (Sigma-Aldrich) for 5 min at room temperature. After three final washes with PBS, slides were mounted with DABCO 1.5% (10 ml DABCO 15% and 90 ml glycerol). Observations were made under a fluorescence microscope (Leica DMRE, Leica Microsystems) and images were captured with a digital camera (Retiga EX; QIMAGING; with OpenLab version 3.1.1 software; Open-Lab). To evaluate the different patterns of the rec-BSPH1 protein at the surface of the sperm, 400 sperm were counted for each condition.
Statistical Analysis
Data are presented as the mean 6 SD. Differences were analyzed by oneway ANOVA followed by the Bonferroni post hoc test using IBM SPSS statistics (version 19). A P value , 0.05 was considered significant.
RESULTS
Expression, Purification, and Biochemical Characteristics
As seen in Figure 1A , during the purification on a His-Bind column, the presence of proteins was observed in each step of the elution with imidazole. Analysis of the peaks by SDS-PAGE under reducing conditions (Fig. 1B) revealed the presence of a protein at ;32 kDa, the expected molecular weight of rec-BSPH1, in every peak (elution fraction [E] 1 to E3). In the first fraction (E1), which corresponds to elution using 100 mM of imidazole, another strong band of ;28 kDa was observed. This band was not present in fractions E2 and E3 (elution with 200 mM and 400 mM imidazole, respectively). However, E2 and E3 showed a faint band at 64 kDa, which was recognized by the anti-rec-BSPH1 antibodies, confirming that it is a rec-BSPH1 dimer (data not shown). Analysis of the elution fractions by SDS-PAGE under nonreducing conditions showed many bands of higher molecular weight (Fig. 1C) . HisProbe monoclonal antibodies (Fig. 1D) and anti-rec-BSPH1 ROLE OF rec-BSPH1 IN SPERM CAPACITATION antibodies (data not shown) both recognized the 32-kDa band and all the higher molecular weight bands in Western blot analysis, indicating that these bands are different oligomeric forms of the recombinant protein. The 28-kDa band recovered in the first elution (E1) was not recognized by either of the two antibodies. LC-MS/MS analysis of the 32-kDa band confirmed the identity of BSPH1 protein (Fig. 1E) . The bands on the SDS-PAGE were scanned and the following proportions were obtained for E2 and E3: monomers (26%), dimers (18%), tetramers (10%), pentamers (7%), and octomers (6%). The remaining 34% were higher molecular weight oligomers, which could not be resolved using 12% polyacrylamide gels. Fraction E2 and E3 were pooled and used for further experiments. E1 was discarded due to the presence of contaminants.
Binding Studies
Binding of rec-BSPH1 to gelatin, heparin, chondroitin sulfate B, PC-liposomes, and sperm membranes was tested. The binding to gelatin and GAGs was assessed by affinity chromatography. When rec-BSPH1 was passed through a gelatin-agarose affinity chromatography column, about 70% of the total protein did not bind to the column (Fig. 2, A and B) . The bound fraction was eluted with 8 M urea. On a heparinsepharose affinity chromatography column, no rec-BSPH1 was found in the unadsorbed fraction (fraction 1), and nearly everything was eluted with 1 M NaCl and 8 M urea (Fig. 2, C  and D) . In contrast, more than 95% of the recombinant protein was found in the unbound fraction when chromatographed on chondroitin sulfate B affinity column. As controls, the binding of bovine BSP proteins and the Trx-His-S was also tested on the three resins used for this study (data not shown). Trx-His-S did not bind to gelatin or chondroitin sulfate B, and bound only slightly to heparin (,20%), while bovine BSP proteins bound strongly to all three resins.
The interaction of rec-BSPH1 with PC-liposomes was evaluated by the ultracentrifugation method. Figure 3A shows that, when PC-liposomes were absent from the incubation medium, all three proteins tested were found in the supernatant after centrifugation. In the presence of PC-liposomes, the majority of rec-BSPH1 was found in the pellet fraction that contained the PC-liposomes. The same result was obtained with the bovine BSP1. In contrast, the Trx-His-S remained in the supernatant fraction. The binding of rec-BSPH1 to sperm membranes was investigated by the centrifugation method. After incubation with sperm, most of the recombinant protein was found in the pellet fraction comprising sperm (Fig. 3B,  bottom panel) . A small amount of the recombinant protein was also detected in the supernatant fraction. The same experiment was done with sperm incubated without the recombinant protein. As seen in the top panel of Figure 3B , a band of ;14 kDa, the expected molecular weight of the native BSPH1, was detected in the pellet fraction. This band was not detected in the supernatant or the wash fractions, and no other bands were detected by the anti-rec-BSPH1 (against His-Tagged protein) or the anti-BSPH1 (against C-terminus peptide) antibodies.
Capacitation Assay
Since only capacitated sperm can undergo the acrosome reaction (AR), capacitation was assessed by the ability of sperm to undergo the AR induced by calcium ionophore A23187. Without the addition of rec-BSPH1 or BSA, the basal level of AR in the presence or absence of A23187 was 23 6 3%. As seen in Figure 4A , 10 lg/ml of rec-BSPH1 was sufficient to cause a significant increase in the percentage of sperm AR induced by A23187 ionophore. Higher concentrations of recombinant protein caused a slight increase in the percentage of AR induced by A23187, but that number reached a plateau around 41 6 6% with 30 lg/ml of rec-BSPH1. BSA alone stimulated the AR induced by A23187 up to 52 6 9%. The addition of Trx-His-S to the media did not increase the level of sperm AR induced by A23187. As seen in Figure 4B , without the addition of calcium ionophore, the level of AR obtained for each condition tested was comparable to the basal AR level. For all the conditions tested, similar results were also observed using CTC staining instead of Coomassie Blue staining (data not shown).
Capacitation Inhibition Assay
Using similar methods, inhibition of capacitation by antirec-BSPH1 antibodies was tested. As seen in Figure 5A , increasing concentrations of anti-rec-BSPH1 antibodies caused a dose-related decrease in the percentage of sperm AR induced by A23187 in the presence of BSA. In this set of experiments, BSA alone stimulated the AR induced by A23187 up to 39 6 3%. The addition of 0.5 lg/ml of anti-rec-BSPH1 antibodies was sufficient to cause a significant decrease of the level of AR induced by A23187 and the addition of 8.4 lg/ml of antibodies decreased the level of AR of sperm back to the level obtained without BSA. When antibodies were added in the absence of BSA, the basal AR level was not affected, and remained the same. The addition of IgG purified from normal rabbit serum had no inhibitory effect unlike anti-rec-BSPH1 antibodies. Without the calcium ionophore, for all conditions tested, levels of AR were not significantly different than the basal level of AR (Fig. 5B) .
Immunolocalization of rec-BSPH1 on Sperm Surface
Localization of rec-BSPH1 on the sperm surface was tested in the presence of rec-BSPH1, with rec-BSPH1 and BSA, and with rec-BSPH1, BSA, and calcium ionophore (Fig. 6A) . When caudal sperm were incubated in those conditions, permeabilized, and immunostained with anti-BSPH1 antibodies and FITC-conjugated secondary antibodies, a clear signal could be observed on the head and/or the midpiece region of the sperm. Immunodetection was tested on both permeabilized and nonpermeabilized sperm (data not shown), and similar results were obtained with both conditions. 
FIG. 3. Binding of rec-BSPH1 to PC liposomes and mouse caudal sperm.
A) A total of 20 lg of rec-BSPH1, 20 lg Trx-His-S, and 10 lg of bovine BSP1 was incubated with or without 300 lg of PC liposomes and then centrifuged. The supernatant (S) and pellet (P) were separated and analyzed by Western blot using mouse anti-rec-BSPH1, His-probe, and bovine anti-BSP1 antibodies, respectively. B) Caudal sperm were incubated with (bottom) or without (top) 10 lg of rec-BSPH1 and then centrifuged. The supernatant (S) was removed and the sperm pellet was washed. The wash fraction (W) and the sperm pellet (P) were separated by centrifugation and equivalent proportions of each fraction were analyzed by Western blot using mouse anti-rec-BSPH1 antibodies.
ROLE OF rec-BSPH1 IN SPERM CAPACITATION
Different controls, in the presence of BSA and without calcium ionophore, were done (Fig. 6B) . When sperm were incubated only in the presence of BSA, a faint signal could be observed on the surface of the sperm (Fig. 6B, top panel, white  arrows) . When sperm were incubated with rec-BSPH1 and IgG purified from normal rabbit serum were substituted as first antibodies, no signal was observed (Fig. 6B, middle panel) . Similarly, no signal was obtained when caudal sperm were incubated with Trx-His-S and with His-probe antibodies as first antibodies (Fig. 6B, bottom panel) . For all controls, sperm were counterstained with Hoechst dye and clear signals for sperm nucleus could be observed confirming the presence of sperm on the slides.
Interestingly, sperm incubated with recombinant proteins showed three different binding patterns. Some sperm had binding only on the acrosome region, some had binding over the midpiece and acrosome regions, and some had proteins only on the midpiece region (Fig. 7, pattern A, B , and C, respectively). In the absence of BSA, 75 6 5% of the sperm had binding only on the head (Fig. 7 , gray bars) and 22 6 4% had binding on the head and the midpiece region (Fig. 7, white  bars) . When BSA was added, in the presence or absence of calcium ionophore, the results were inverted. Approximately 65 6 4% of the sperm had binding on the midpiece region and the head, and 30 6 5% had binding only on the head. The sperm fraction with binding only on the midpiece region (Fig.  7, black bars) was negligible for all conditions tested.
DISCUSSION
Expression, Purification, and Biochemical Characteristics
The choice of the expression system, namely E. coli Origami B (DE3)pLysS and pET32a vector, to produce recombinant BSP proteins has been thoroughly discussed in a previous publication [35] . With this expression system alone, a good level of rec-BSPH1 could be obtained, but some problems regarding protein aggregation, solubility, and purity were observed. To resolve these issues, a purification step using on-column refolding was added. The use of 6 M urea to denature the protein aggregates followed by a decreasing gradient from 6 to 0 M urea on column was adequate to reduce the number of high molecular weight aggregates that were initially present. The use of this purification method resulted in the presence of soluble, pure proteins with different levels of oligomerization. This is consistent with previous observations in other species, such as bull, stallion, ram, and boar [12, 24, 25, 39, 40] .   FIG. 4 . Effect of rec-BSPH1 on murine sperm capacitation. Capacitation was assessed by the ability of sperm to undergo the AR induced by A23187 ionophore. Epididymal sperm were incubated with different concentrations of rec-BSPH1 or 32 lg/ml of Trx-His-S in the presence or absence of 5 mg/ml of BSA for 60 min followed by incubation with (A) or without (B) calcium ionophore A23187 for 30 min. Sperm were smeared on slides and analyzed by Coomassie Blue staining. A minimum of 400 sperm per condition was evaluated. Data are means 6 SD for four independent experiments. *Significant difference compared to control without BSA and rec-Bsph1 (P , 0.05).
FIG. 5. Effect of anti-rec-BSPH1 on murine spermatozoa capacitation.
Capacitation was assessed by the ability of sperm to undergo the AR induced by A23187 ionophore. Epididymal sperm were incubated with or without 5 mg/ml of BSA and different concentrations of anti-rec-BSPH1 antibodies or control IgG for 60 min, followed by incubation with (A) or without (B) calcium ionophore A23187 for 30 min. Sperm were smeared on slides and analyzed by Coomassie Blue staining. A minimum of 400 sperm per condition was evaluated. Data are means 6 SD for four independent experiments. *Significant difference compared to BSA alone (control; P , 0.05).
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It has been established that most proteins from the binder of sperm family bind to heparin, and some of them also bind to chondroitin sulfate B. The ability of proteins to bind GAGs is attributed to conserved patterns of basic amino acids in the protein sequences. Because heparin is the most negatively charged GAG, it binds more strongly to ligand than other GAGs [41, 42] . The murine BSPH1 protein contains very few consensus basic amino acid sequences, which could explain why rec-BSPH1 could bind to heparin, but not to chondroitin sulfate B, a less negatively charged GAG.
BSP proteins also have the ability to bind to gelatin, a property attributed to the presence of two Fn2 domains [13] . The significance of this property is currently unknown, but has been exploited for the purification of BSP proteins from seminal plasma of several ungulates (bull, ram, bison, goat, and stallion) [13, [22] [23] [24] . Even though rec-BSPH1 contains Fn2 domains, ;30% of the total proteins loaded bound strongly to gelatin. Attempts to dialyze with redox system or gradual elimination of urea did not improve binding significantly. The reason for reduced binding is unknown, but it could be conformation related, or mostly due to the masking of gelatin binding sites following aggregation, or to some unknown reasons. The bulky trx in aggregated recombinant may also interfere with or mask the gelatin binding sites. It is worth mentioning that the recombinant AB domain and the recombinant full-length bovine BSP5 protein do not bind gelatin, yet are able to promote sperm capacitation (P.S. Jois, personal communication). In the current study, we used rec-
Immunostaining of rec-BSPH1 on cauda epididymal sperm. A) Sperm collected from cauda epididymis were incubated alone or in media containing 15 lg rec-BSPH1 and BSA with or without A23187. Slides were incubated with anti-rec-BSPH1 antibodies at a dilution of 1:100 and treated with FITC-conjugated IgG. B) For detection of native proteins, cauda epididymal sperm were incubated without recombinant proteins, smeared on slides, and incubated with anti-rec-BSPH1 antibodies at a dilution of 1:100. For the two controls, cauda epididymal sperm were incubated with 15 lg rec-BSPH1 or 7 lg Trx-His-S and smeared on slides and incubated with IgG or His-probe antibodies, respectively, at a dilution of 1:100. All slides were then treated with goat anti-mouse/anti-rabbit FITC-conjugated IgG (right) and counterstained with Hoechst dye to localize nuclei (left). Original magnification 31250.
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BSPH1 for functional studies without fractionation on gelatinagarose column.
Another intrinsic characteristic shared among proteins of the BSP superfamily is the ability to interact with choline containing phospholipids, such as PC [14, 21, 43] . Crystallography studies have shown that PC interacts with BSP proteins through a cation interaction between the quaternary amine group of the choline and a tryptophan residue of the Fn2 domains, as well as through hydrogen bonds between three tyrosine residues of the protein and phosphate groups [44] . Since those tyrosine and tryptophan residues of the Fn2 domains are conserved between the bovine BSP proteins and the BSPH1 protein sequence [29] , it is not surprising to see that the murine homolog also interacts with PC liposomes.
Choline phospholipids (PC and sphingomyelin) represent ;70% of total phospholipids in murine epididymal sperm plasma membranes [45] . This could explain the binding of BSPH1 to sperm membranes, as observed with bovine BSP proteins [46] . As seen in Figure 3B , native BSPH1 is found in the sperm pellet after ultracentrifugation. Incubation of sperm in the presence of rec-BSPH1 gave similar results, but a stronger signal was observed. While the presence of PC and sphingomyelin in sperm membranes explains the binding of rec-BSPH1 to sperm, rec-BSPH1 could also bind sperm via the native BSPH1 already bound to choline groups on the sperm surface (protein-protein interaction). It has been demonstrated that bovine BSP1 binds sperm via an interaction with choline phospholipids on the sperm surface, as well as by selfassociation on the sperm surface [47] . Immunolocalization studies clearly confirmed the binding of native and recombinant BSPH1 to the sperm surface.
In bovine ejaculated sperm, BSP proteins have been shown to bind over the head and midpiece region of sperm [46] . In the current study, rec-BSPH1 was shown to bind to the same regions of sperm, but a greater proportion of sperm had binding over the midpiece region in the presence of BSA. These results are similar to those reported with bovine BSPs. Bovine epididymal sperm incubated with BSP1 show intense fluorescence on the acrosome region, whereas, on sperm incubated with oviductal fluid, which is composed of 85% albumin, BSP1 and BSP3 are more concentrated on the midpiece region [18, 48] . The midpiece of spermatozoa is the region containing mitochondria, and is often associated with sperm motility. Since it has already been shown that bovine BSP1 stimulates sperm motility and the activity of membrane-bound calcium ATPase in bull semen [31, 49] , it is likely that BSPH1 may play a role in motility as well.
Role in Sperm Capacitation
The main function ascribed to BSP proteins in bovine and boar is to promote sperm capacitation [26, 50] . The current study shows that rec-BSPH1 can promote capacitation, and joins a list of other murine epididymal proteins with a role in capacitation, such as CRISP-1 and HongrES1 [51, 52] . In order to study the effect of BSP proteins on capacitation in the bovine model, washed epididymal sperm are incubated with appropriate protein concentrations, the excess or unbound BSP proteins are removed by washing, and sperm are reincubated for 4-5 h with capacitation factor (heparin) [16, 31] . Since murine sperm are very fragile [53] , to better suit the mouse model, the conditions used for capacitation were different than those used in the bovine model. Mouse sperm were incubated in continuous presence of rec-BSPH1 to avoid additional manipulations and centrifugation steps. The physiological concentrations of BSPH1 protein in mouse epididymis are unknown, but immunodetection experiments with epididymal sperm and tissue extracts suggest that it is quite low. For this reason, rec-BSPH1 ranging from 1 to 60 lg/ml was used. It is important to note that the tag fused to the recombinant protein accounts for 53% of the total protein. Therefore, the actual BSPH1 concentrations used in the functional experiments ranged from 470 ng/ml to 28 lg/ml.
At concentrations lower than 10 lg/ml, which are probably closer to concentrations found in vivo, AR levels induced by A23187 did not increase. It has been demonstrated with bovine sperm that, in order to promote sperm capacitation, BSP proteins need HDL or excess free BSP to act as acceptors to induce lipid efflux [16, 50, 54, 55] . In a similar manner, in this study, when low concentrations were used, all the protein bound to sperm surface and none was available to remove lipids from the sperm surface. When higher concentrations are present in the media, free BSPH1 may act as acceptor to remove phospholipids and cholesterol from sperm membranes, which could lead to capacitation. Thus, in vivo, sperm bound BSPH1 would need to interact with components of the oviductal fluid to promote capacitation (Fig. 8) .
To better understand the mechanism of the native BSPH1 in sperm capacitation, the effect of antibodies on capacitation was PLANTE ET AL. also tested as previously described [56, 57] . Without BSA, the anti-rec-BSPH1 antibodies did not decrease the AR, which remained at the basal level, indicating that native (endogenous) BSPH1 is not sufficient to stimulate an increase in capacitation. The effect of antibodies was then tested on BSA-induced capacitation to see if anti-rec-BSPH1 could block capacitation induced by other factors. These experiments showed that 500 ng/ml anti-rec-BSPH1 antibodies were sufficient to reduce significantly the level of sperm capacitation induced by 5 mg/ ml BSA. BSP proteins bind sperm surface via an interaction with the choline group of phospholipids [14] , and BSA has been shown to interact with the acyl chain of phosphatidylcholine [58] . Anti-rec-BSPH1 antibodies could inhibit BSAinduced capacitation by binding native BSPH1 on the sperm surface, preventing BSA from acting to remove sterols from sperm membranes. Bovine BSP proteins are known to coat the sperm surface, prevent free movement of the phospholipids, and stabilize sperm membrane [59, 60] . Another explanation could be that, in a similar manner, binding of antibodies to the native BSPH1 on the sperm surface possibly created a stable network between BSPH1 proteins, thereby preventing movements of the lipids and further stabilizing the sperm membrane, rendering capacitation induced by the BSA impossible.
Murine BSPH1 differs from other BSP proteins as it is secreted by the epididymis and is found in low concentrations.
Since epididymal maturation is a long process, it is likely that the expression of low concentrations of BSPH1 prevents detrimental effects that BSP proteins could exert. Instead, during epididymal maturation, BSPH1 proteins could be binding to the sperm surface to stabilize the membrane and prevent premature capacitation and AR. Following ejaculation and the journey through the female genital tract, BSPH1 could interact, in the oviduct, with HDL or other factors to promote sperm capacitation (Fig. 8) .
In conclusion, a suitable method for the expression and the purification of rec-BSPH1 was developed to produce soluble and less aggregated proteins. The recombinant protein showed binding properties similar to other BSP proteins. This study is the first to demonstrate the implication of an epididymal protein from the BSP superfamily in capacitation, and the first to assess the role of a BSP from rodents in sperm function. Furthermore, it is the first study using recombinant full-length BSP proteins to assess sperm function. Further work is needed to understand the exact mechanism by which mouse BSPH1 could promote sperm capacitation via its interaction with oviductal fluid components. Other putative functions, such as sperm-egg interaction, also warrant investigation. Finally, the role of the second murine BSP protein homolog (BSPH2) in sperm functions also requires study. In view of the fact that murine BSPH1 shares a high level of sequence identity with 
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the human epididymal BSP homolog 1 (BSPH1), this study could also help to improve understanding of the role of the BSP protein in human.
